NASDAQ: FRES - Fresh2 Group Limited

Rentabilität für sechs Monate: -74.63%
Dividendenrendite: 0.00%
Sektor: Healthcare

Aktionsplan Fresh2 Group Limited

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen Fresh2 Group Limited

Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc.

weitere details
In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is headquartered in Shanghai, the People's Republic of China.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

IPO date 2023-05-22
ISIN US03635R2067
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета cny
Сайт https://fresh2.co
Цена ао 1.45
Preisänderung pro Tag: 0% (0.85)
Preisänderung pro Woche: -24.11% (1.1201)
Preisänderung pro Monat: -35.32% (1.3142)
Preisänderung über 3 Monate: -37.5% (1.36)
Preisänderung über sechs Monate: -74.63% (3.35)
Preisänderung pro Jahr: -4.49% (0.89)
Preisänderung über 3 Jahre: -20.56% (1.07)
Preisänderung über 5 Jahre: 0% (0.85)
Preisänderung über 10 Jahre: 0% (0.85)
Preisänderung seit Jahresbeginn: -48.17% (1.6401)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Gesamt: 2.5

Effizienz

Name Bedeutung Grad
ROA, % 0 0
ROE, % 0 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0 0
Gesamt: 0

Pflicht

Name Bedeutung Grad
Debt/EBITDA 0 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 667.38 10
Rentabilität Ebitda, % 694.75 10
Rentabilität EPS, % 7232.82 10
Gesamt: 10
Weitere Details

Institutionen Volumen Aktie, %
UBS Group AG 33522 0.38
Rhumbline Advisers 6678 0.08

ETF Aktie, % Rentabilität für das Jahr, % Dividenden, %
Global X Silver Miners ETF 2.96144 30.27 0.89084
First Trust United Kingdom AlphaDEX Fund 1.34153 -98.5 3.58756
VanEck Junior Gold Miners ETF 1.16561 39.99 1.00992
Amplify Junior Silver Miners ETF 1.00793 17.15 0.41308
First Trust Europe AlphaDEX Fund 0.62354 5.72 5.23762
Goldman Sachs Access Investment Grade Corporate Bond ETF 0.13903 -1.31 3.33165
Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF 0.10418 2.77 3.5165
Schwab Fundamental International Small Co. Index ETF 0.06152 8.31 3.46652
Dimensional International Small Cap Value ETF 0.05112 7.13 4.55441
Dimensional International Small Cap ETF 0.04916 5.69 3.34747
Franklin FTSE United Kingdom ETF 0.04783 11.97 3.85523
PMXF Diversified Return Intl Ex-North America Equity 0.04658 2.11 4.09594
Dimensional International Core Equity 2 ETF 0.01522 6.52 3.69996
JPMorgan BetaBuilders Europe ETF 0.0118 5.19 3.612
Franklin FTSE Europe ETF 0.0118 8.4 3.62341
IQ Candriam International Equity ETF 0.01112 10.11 3.0914
SPDR Portfolio Europe ETF 0.01069 8.94 3.66537
Vanguard ESG International Stock ETF 0.01 6.39 3.07501
Dimensional World ex U.S. Core Equity 2 ETF 0.00842 13.06 3.62488
BNY Mellon International Equity ETF 0.00825 11.1 3.33394
Goldman Sachs MarketBeta International Equity ETF 0.00801 5.33 3.36845
JPMorgan BetaBuilders International Equity ETF 0.0077 4.72 3.37709
Schwab International Equity ETF 0.00635 5.11 3.33884
SPDR Portfolio Developed World ex-US ETF 0.00628 5.29 3.28401
Dimensional International Core Equity Market ETF 0.00433 13.09 3.48343
Avantis International Equity ETF 0.00202 6.46 3.80856



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Haohan Xu Chairman of the Board & CEO N/A 1995 (30 Jahre)
Ms. Xiaoyu Li Director & CFO N/A 1989 (36 Jahre)
Mr. Weidong Dai China President N/A 1961 (64 Jahr)
Dr. Sunil Pandit U.S. Chief Executive Officer N/A
Mr. Yidong Hu Chief Strategy Officer N/A

Adresse: United States, New York, 650 5th Ave - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://fresh2.co